• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • COPD Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: EcuadorChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
    Format: 
    • Expert Video
    • Podcast
    • Slide presentation
    • Infographic
    • Video animation
    • Interactivity
    Length: 
    • Short (<5 minutes)
    • Medium (5-15 minutes)
    • Long (> 15 minutes)
    Sort by: Newest
    • Newest
    • Oldest
    • A-Z
    • Z-A
    EoE Pocket Guide
    Gastroenterology
    5 min
    interactivity

    EoE Pocket Guide

    Mechanisms of Production and Clinical Impact of IgE
    Pulmonology
    5 min
    videoanimation

    Mechanisms of Production and Clinical Impact of IgE

    Pathways to Disease: Inflammation in Chronic Obstructive Pulmonary Disease Video
    Pulmonology
    4 min
    videoanimation

    Pathways to Disease: Inflammation in Chronic Obstructive Pulmonary Disease Video

    Exploring the Mechanisms of FeNO Production in the Lungs
    Pulmonology
    4 min
    videoanimation

    Exploring the Mechanisms of FeNO Production in the Lungs

    How Type 2 Inflammation Drives Eosinophils in Asthma
    Pulmonology
    4 min
    videoanimation

    How Type 2 Inflammation Drives Eosinophils in Asthma

    Digging Deeper: Reducing Non-Atopic Comorbidities and Multidimensional Disease Burden
    Dermatology
    3 min
    expert video

    Digging Deeper: Reducing Non-Atopic Comorbidities and Multidimensional Disease Burden

    On the Surface: Restoring the Skin Barrier in Patients with AD
    Dermatology
    2 min
    expert video

    On the Surface: Restoring the Skin Barrier in Patients with AD

    ADVENT On Air | Be on the Lookout for EoE: The Importance of Early Diagnosis
    Gastroenterology
    18 min
    Podcast

    ADVENT On Air | Be on the Lookout for EoE: The Importance of Early Diagnosis

    Hindered Growth in Children Aged <12 Years with Moderate-to-Severe AD and Potential Improvement with Dupilumab Treatment
    Dermatology
    4 min
    expert video

    Hindered Growth in Children Aged <12 Years with Moderate-to-Severe AD and Potential Improvement with Dupilumab Treatment

    Underlying Type 2 Inflammation Drives a Chronic Itch-Scratch Cycle in Atopic Dermatitis
    Type 2 Inflammation
    3 min
    expert video

    Underlying Type 2 Inflammation Drives a Chronic Itch-Scratch Cycle in Atopic Dermatitis

    From Protective Type 2 Immunity to Aberrant Type 2 Inflammation
    Type 2 Inflammation
    3 min
    expert video

    From Protective Type 2 Immunity to Aberrant Type 2 Inflammation

    The Effects of Chronic Spontaneous Urticaria on Mental Health and Quality of Life
    Dermatology
    2 min
    expert video

    The Effects of Chronic Spontaneous Urticaria on Mental Health and Quality of Life

      1234
      ...
      26